Cerebain Biotech Announces Next Phase As It Continues To Wage War Against Alzheimer’s And Dementia

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

DALLAS--(BUSINESS WIRE)--Cerebain Biotech Corp. (“Cerebain” or “the Company”), a subsidiary of Discount Dental Materials, Inc. (OTCBB: DDOO), announced that medical device product development company, Sonos Models, Inc. (“Sonos Product Development”), has made progress based on results of research of the first Prototypes of Cerebain’s Medical Device Product for the treatment of Alzheimer’s.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC